Search Browse Earnings

Eton Pharmaceuticals, Inc.

Nasdaq:ETON

Pharmaceutical Preparations·DEER PARK, IL

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Eton Pharmaceuticals, Inc. — SlamSEC

Revenue

$21.3M

-2.7% YoY

FY 2024

Adj. EBITDA

-$7.9M

-37.2% margin

FY 2024

Net Income

-$9.0M

-42.4% margin

FY 2024

EPS (Diluted)

-$0.36

FY 2024

Stock Price

$16.43

-4.8%

2026-03-09

52W Range

$11.09 – $23.00

P/E Ratio

-45.6x

Market Cap

$440.6M

Cash

$21.4M

FY 2024

Total Debt

—

Net Cash

$21.4M

FY 2024

Enterprise Value

$419.2M

Debt / EBITDA

2.7x

FY 2024

EV / EBITDA

-53.0x

Employees

—

CEO

Brynjelsen Sean